Risk Partners Life Sciences Roundtable 2024, thank you very much! Already for the 26.06.2025 >
Last year, more than 10 percent of German companies were affected by an IT security incident, with the proportion increasing due to cyber attacks. Biotechnology is not excluded either. It is possible to learn from the Evotec case.
It is about successful cyber attacks or other incidents that are important for security, such as acts of sabotage or hardware theft. According to a representative Ipsos survey conducted on behalf of the TÜV association among 501 companies with more than ten employees. According to TÜV, around 50,000 incidents in this size category were recorded in absolute figures in June. Hacker attacks cause enormous damage to the German economy and are estimated at 200 billion euros annually.
Last year, more than 10 percent of German companies were affected by an IT security incident, with the proportion increasing due to cyber attacks. Biotechnology is not excluded either. It is possible to learn from the Evotec case.
It is about successful cyber attacks or other incidents that are important for security, such as acts of sabotage or hardware theft. According to a representative Ipsos survey conducted on behalf of the TÜV association among 501 companies with more than ten employees. According to TÜV, around 50,000 incidents in this size category were recorded in absolute figures in June. Hacker attacks cause enormous damage to the German economy and are estimated at 200 billion euros annually.
Incorrect configurations or inadequately managed user accounts are examples of this. Hackers are also increasingly attacking pharmaceutical and biotech companies and the healthcare sector as a whole, and the public is now hearing about this more frequently than before, including at an international level. In June, the Japanese company Eisai announced that it had been affected by a ransomware attack. In March, Sun Pharmaceuticals discovered that some of its file systems had been compromised by an attack. Last year, Novartis was hit by such an attack. In 2020, AstraZeneca was attacked by hackers. In 2017, malware damaged Merck's computers in what may be the most high-profile case in history. This cost the company hundreds of millions of dollars and affected the production of its HPV vaccine.
However, Evotec's management team, consisting of Werner Lanthaler and Matthias Evers, tried to demonstrate their ability to act and presented an example of how fast and transparent communication is possible in a highly sensitive area of data security in order to strengthen trust instead of losing it. Evotec is a global biotechnology company with many pharmaceutical partnerships and multiple sites.
A sum of 70 to 90 million euros can be gained from lost business with partners, a complete IT failure and the establishment of a secure new IT environment.
Congratulations to Formycon AG on its successful uplisting to the Prime Standard of Deutsche Börse on November 12, 2024! Welcome to the Prime Standard league: A new champion of life sciences and biosimilars has successfully made the step from the Scale segment. We proudly congratulate Enno Spillner, Dr. Caroline Redeker, Daniel Marquard
We congratulate Steyr Motors AG on its successful listing in the Scale Segment of the German Stock Exchange on October 30, 2024! Risk Partners had the honor to act as IPO underwriting advisor on this transaction. Our team, led by Florian Eckstein and Björn Stressenreuter, supported Steyr Motors AG in its IPO on the Frankfurt Stock Exchange.
𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝘁𝗲𝗴𝗿𝗶𝘁𝘆 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗙𝗼𝗿𝘂𝗺 𝟮𝟬𝟮𝟮𝟰 "D&O and Co. - Plan B to cover personal liability!" Last Friday, Florian had the honor of taking part in the Global Integrity and Compliance Forum at the Ludwig-Maximilians-Universität in Munich. Under the motto "The RULE of LAW in the Era of Integrity & Compliance", the event brought together
Research mishap at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research - can you insure against it? An incident that threatens your very existence, but which we would like to shed some light on from the perspective of an insurance broker specializing in life sciences. What happened? At the Karolinska Institute in Stockholm, Sweden's most important medical research center, a
OLG Schleswig: Limitation of liability claims in the case of direct claims in D&O insurance. There is a new, exciting ruling from the world of D&O insurance. We recently reported on the decision of the Higher Regional Court of Cologne in the context of direct claims. Now the Higher Regional Court of Schleswig has also made a groundbreaking decision. What was it about? At the center
Growth capital for biotechnology and life sciences - Finance Day 2024 A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. Since three of our consulting focus areas, namely the areas of Life
Everything you need to know to optimally protect you and your life sciences / biotech company.
